General Statement of Disclosure:

RESEARCH/RESEARCH GRANTS: Eli Lilly(SIGNIFICANT), Amgen(SIGNIFICANT), Astra Zeneca(SIGNIFICANT), Esperion Therapeutics(SIGNIFICANT), Medtronic(NONE), Novartis(SIGNIFICANT), Silence Therapeutics(SIGNIFICANT), AstraZeneca Pharmaceuticals(SIGNIFICANT), AbbVie, Inc.(SIGNIFICANT), Bristol-Myers Squibb Company (SIGNIFICANT), Mineralys(SIGNIFICANT), New Amsterdam Pharmaceuticals(SIGNIFICANT), Bristol Myers Squibb(SIGNIFICANT), Arrowhead(SIGNIFICANT), Encarda(SIGNIFICANT) OTHER FINANCIAL BENEFIT: Editor, Current Cardiology Reports (Springer Nature(SIGNIFICANT)

View Full Disclosure